Impact of DNA methyltransferases on the epigenetic regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in malignant melanoma

Biochemical and Biophysical Research Communications

Volumn 441, Issue 4, 2013, Pages 743-750

  Venza, Mario ^a   Visalli, Maria ^b   Catalano, Teresa ^b   Fortunato, Cinzia ^b   Oteri, Rosaria ^b   Teti, Diana ^b   Venza, Isabella ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Cutaneous melanoma; DNA methyltransferases; Gene expression; Promoter methylation; TRAIL receptors; Uveal melanoma

Indexed keywords

DEATH RECEPTOR 4; DEATH RECEPTOR 5; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; MESSENGER RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR 3;

ADULT; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CUTANEOUS MELANOMA; DNA METHYLATION; EPIGENETICS; FEMALE; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MELANOMA; MELANOMA CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; UPREGULATION; UVEA MELANOMA;

CUTANEOUS MELANOMA; DNA METHYLTRANSFERASES; GENE EXPRESSION; PROMOTER METHYLATION; TRAIL RECEPTORS; UVEAL MELANOMA;

CARCINOGENESIS; CELL LINE, TUMOR; DNA METHYLATION; DNA-CYTOSINE METHYLASES; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GPI-LINKED PROTEINS; HUMANS; MELANOMA; SKIN NEOPLASMS; TUMOR NECROSIS FACTOR DECOY RECEPTORS; UVEAL NEOPLASMS;

EID: 84888854875     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.10.114     Document Type: Article

References (23)

1. Venza I., Visalli M., Oteri R., et al. Class II-specific histone deacetylase inhibitors MC1568 and MC1575 suppress IL-8 expression in human melanoma cells. Pigment Cell Melanoma Res. 2013, 26:193-204.
2. Richards H.W., Medrano E.E. Epigenetic marks in melanoma. Pigment Cell Melanoma Res. 2009, 22:14-29.
3. Muthusamy V., Duraisamy S., Bradbury C.M., et al. Epigenetic silencing of novel tumor suppressors in malignant melanoma. Cancer Res. 2006, 66:11187-11193.
4. Zhuang L., Lee C.S., Scolyer R.A., et al. Progression in melanoma is associated with decreased expression of death receptors for tumor necrosis factor-related apoptosis-inducing ligand. Hum. Pathol. 2006, 37:1286-1294.
5. Walczak H., Miller R.E., Ariail K., et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med. 1999, 5:157-163.
6. Pan G., Ni J., Wei Y.F., et al. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 1997, 277:815-818.
7. Malhi H., Gores G.J. TRAIL resistance results in cancer progression: a TRAIL to perdition?. Oncogene 2006, 25:7333-7335.
8. Degli-Esposti M.A., Dougall W.C., Smolak P.J., et al. The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity 1997, 7:813-820.
9. Sheikh M.S., Jr A.J. Fornace, death and decoy receptors and p53-mediated apoptosis. Leukemia 2000, 14:1509-1513.
10. Bae S.I., Cheriyath V., Jacobs B.S., et al. Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL. Oncogene 2008, 27:490-498.
11. Bonazzi V.F., Nancarrow D.J., Stark M.S., et al. Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma. PLoS ONE 2011, 6:e26121.
12. Smith S.S. Biological implications of the mechanism of action of human DNA (cytosine-5)methyltransferase. Prog. Nucleic Acid Res. Mol. Biol. 1994, 49:65-111.
13. Okano M., Bell D.W., Haber D.A., et al. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999, 99:247-257.
14. Belinsky S.A., Nikula K.J., Baylin S.B., et al. Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer. Proc. Natl. Acad. Sci. USA 1996, 93:4045-4050.
15. Robertson K.D. DNA methylation, methyltransferases, and cancer. Oncogene 2001, 20:3139-3155.
16. Venza I., Visalli M., Fortunato C., et al. PGE2 induces interleukin-8 derepression in human astrocytoma through coordinated DNA demethylation and histone hyperacetylation. Epigenetics 2012, 7:1315-1330.
17. Gopisetty G., Ramachandran K., Singal R. DNA methylation and apoptosis. Mol. Immunol. 2006, 43:1729-1740.
18. van Noesel M.M., van Bezouw S., Salomons G.S., et al. Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation. Cancer Res. 2002, 62:2157-2161.
19. Shivapurkar N., Toyooka S., Toyooka K.O., et al. Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types. Int. J. Cancer 2004, 109:786-792.
20. Rhee I., Bachman K.E., Park B.H., et al. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature 2002, 416:552-556.
21. Fatemi M., Hermann A., Gowher H., et al. Dnmt3a and Dnmt1 functionally cooperate during de novo methylation of DNA. Eur. J. Biochem. 2002, 269:4981-4984.
22. Chaudhary P.M., Eby M., Jasmin A., et al. Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. Immunity 1997, 7:821-830.
23. Gilmore T.D., Koedood M., Piffat K.A., et al. Rel/NF-kappaB/IkappaB proteins and cancer. Oncogene 1996, 13:1367-1378.